{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:25:47Z","timestamp":1764044747613,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015278","name":"Pfizer Healthcare Ireland","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100015278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Growth hormone deficiency (GHD) has been implicated in increased cardiovascular and cerebrovascular disease risk seen in hypopituitarism, however the mechanism remains speculative. We hypothesise that platelet abnormalities may play a contributory role. Herein we examined platelet behaviour in GHD hypopituitary patients, pre- and post-growth hormone (GH) replacement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study utilizes a physiological flow-based assay to quantify platelet function in whole blood from patient cohorts under arterial shear. Thirteen GH Na\u00efve hypopituitary adults with GHD and thirteen healthy matched controls were studied. Patients were assessed before and after GH treatment. All other pituitary replacements were optimised before the study. In addition to a full endocrine profile, whole blood was labelled and perfused over immobilised von Willibrand factor (vWF). Seven parameters of dynamic platelet-vWF interactions were recorded using digital image microscopy and analysed by customised platelet tracking software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found a significantly altered profile of platelet-vWF interactions in GHD individuals compared to healthy controls. Specifically, we observed a marked increase in platelets shown to form associations such as tethering, rolling and adherence to immobilized vWF, which were reduced post GH treatment. Speed and distance platelets travelled across vWF was similar between controls and pre-therapy GHD patients, however, this was considerably increased post treatment. This may indicate reduced platelet signaling resulting in less stable adhesion of platelets post GH treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taken together observed differences in platelet behaviour may contribute to an increased risk of thrombosis in GHD which can in part be reversed by GH therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01448-6","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:26:06Z","timestamp":1694661966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Irene K","family":"Oglesby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saket","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eimear","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife","family":"Garrahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan","family":"Toner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dermot","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"8710","key":"1448_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-o","volume":"336","author":"T Ros\u00e9n","year":"1990","unstructured":"Ros\u00e9n T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336(8710):285\u20138. https:\/\/doi.org\/10.1016\/0140-6736(90)91812-o.","journal-title":"Lancet"},{"issue":"9254","key":"1448_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s0140-6736(00)04006-x","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM. Association between premature mortality and hypopituitarism. West midlands prospective Hypopituitary Study Group. Lancet. 2001;357(9254):425\u201331. https:\/\/doi.org\/10.1016\/s0140-6736(00)04006-x.","journal-title":"Lancet"},{"issue":"3","key":"1448_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM. Mortality in patients with pituitary disease. Endocr Rev. 2010;31(3):301\u201342. https:\/\/doi.org\/10.1210\/er.2009-0033.","journal-title":"Endocr Rev"},{"key":"1448_CR4","doi-asserted-by":"crossref","unstructured":"Vance ML, Hypopituitarism. N Engl J Med. 1994;330(23):1651-62. doi: 10.1056\/NEJM199406093302306. Erratum in: N Engl J Med 1994;331(7):487.","DOI":"10.1056\/NEJM199406093302306"},{"issue":"3","key":"1448_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1210\/jcem.81.3.8772595","volume":"81","author":"AS Bates","year":"1996","unstructured":"Bates AS, Van\u2019t Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81(3):1169\u201372. https:\/\/doi.org\/10.1210\/jcem.81.3.8772595.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1448_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-e","volume":"42","author":"RC Cuneo","year":"1993","unstructured":"Cuneo RC, Salomon F, Watts GF, Hesp R, S\u00f6nksen PH. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 1993;42(12):1519\u201323. https:\/\/doi.org\/10.1016\/0026-0495(93)90145-e.","journal-title":"Metabolism"},{"issue":"2","key":"1448_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","volume":"43","author":"H de Boer","year":"1994","unstructured":"de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. Serum lipid levels in growth hormone-deficient men. Metabolism. 1994;43(2):199\u2013203. https:\/\/doi.org\/10.1016\/0026-0495(94)90245-3.","journal-title":"Metabolism"},{"key":"1448_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-4899-1268-8_53","volume":"60","author":"L L\u00f6nn","year":"1993","unstructured":"L\u00f6nn L, Kvist H, Grang\u00e5rd U, Bengtsson BA, Sj\u00f6str\u00f6m L. CT-determined body composition changes with recombinant human growth hormone treatment to adults with growth hormone deficiency. Basic Life Sci. 1993;60:229\u201331. https:\/\/doi.org\/10.1007\/978-1-4899-1268-8_53.","journal-title":"Basic Life Sci"},{"issue":"26","key":"1448_CR9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","volume":"321","author":"F Salomon","year":"1989","unstructured":"Salomon F, Cuneo RC, Hesp R, S\u00f6nksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321(26):1797\u2013803. https:\/\/doi.org\/10.1056\/NEJM198912283212605.","journal-title":"N Engl J Med"},{"issue":"1","key":"1448_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/eje.1.01817","volume":"152","author":"CL Boguszewski","year":"2005","unstructured":"Boguszewski CL, Meister LH, Zaninelli DC, Radominski RB. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults. Eur J Endocrinol. 2005;152(1):67\u201375. https:\/\/doi.org\/10.1530\/eje.1.01817.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1448_CR11","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1210\/jcem.87.7.8655","volume":"87","author":"RJ Irving","year":"2002","unstructured":"Irving RJ, Carson MN, Webb DJ, Walker BR. Peripheral vascular structure and function in men with contrasting GH levels. J Clin Endocrinol Metab. 2002;87(7):3309\u201314. https:\/\/doi.org\/10.1210\/jcem.87.7.8655.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1448_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jcem.84.2.5456","volume":"84","author":"M Pfeifer","year":"1999","unstructured":"Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab. 1999;84(2):453\u20137. https:\/\/doi.org\/10.1210\/jcem.84.2.5456.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1448_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-2265.2002.01559.x","volume":"57","author":"RW McCallum","year":"2002","unstructured":"McCallum RW, Petrie JR, Dominiczak AF, Connell JM. Growth hormone deficiency and vascular risk. Clin Endocrinol (Oxf). 2002;57(1):11\u201324. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01559.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7329","key":"1448_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collabora","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71\u201386. https:\/\/doi.org\/10.1136\/bmj.324.7329.71. Erratum in: BMJ 2002;324(7330):141.","journal-title":"BMJ"},{"issue":"6922","key":"1448_CR15","first-page":"159","volume":"308","author":"Collaborative overview of randomised trials of antiplatelet therapy","year":"1994","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy\u2013II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists\u2019 Collaboration BMJ. 1994;308(6922):159\u201368.","journal-title":"Antiplatelet Trialists\u2019 Collaboration BMJ"},{"issue":"4093","key":"1448_CR16","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1126\/science.180.4093.1332","volume":"180","author":"R Ross","year":"1973","unstructured":"Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973;180(4093):1332\u20139. https:\/\/doi.org\/10.1126\/science.180.4093.1332.","journal-title":"Science"},{"issue":"7","key":"1448_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM197608122950707","volume":"295","author":"R Ross","year":"1976","unstructured":"Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976;295(7):369\u201377. https:\/\/doi.org\/10.1056\/NEJM197608122950707.","journal-title":"N Engl J Med"},{"issue":"8","key":"1448_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1056\/NEJM197608192950805","volume":"295","author":"R Ross","year":"1976","unstructured":"Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med. 1976;295(8):420\u20135. https:\/\/doi.org\/10.1056\/NEJM197608192950805.","journal-title":"N Engl J Med"},{"issue":"8928","key":"1448_CR19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(94)91646-2","volume":"344","author":"Platelet activation and arterial thrombosis","year":"1994","unstructured":"Platelet activation and arterial thrombosis. Report of a meeting of Physicians and scientists, University of Texas Health Science Center at Houston and Texas Heart Institute. Houst Lancet. 1994;344(8928):991\u20135. PMID: 7934435.","journal-title":"Houst Lancet"},{"issue":"12","key":"1448_CR20","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1161\/01.RES.0000267878.97021.ab","volume":"100","author":"ZM Ruggeri","year":"2007","unstructured":"Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res. 2007;100(12):1673\u201385. https:\/\/doi.org\/10.1161\/01.RES.0000267878.97021.ab.","journal-title":"Circ Res"},{"issue":"5","key":"1448_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0092-8674(00)81607-4","volume":"94","author":"B Savage","year":"1998","unstructured":"Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657\u201366. https:\/\/doi.org\/10.1016\/s0092-8674(00)81607-4.","journal-title":"Cell"},{"issue":"2","key":"1448_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s0092-8674(00)80983-6","volume":"84","author":"B Savage","year":"1996","unstructured":"Savage B, Sald\u00edvar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84(2):289\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(00)80983-6.","journal-title":"Cell"},{"issue":"10","key":"1448_CR23","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1210\/jc.2004-0511","volume":"89","author":"A Agha","year":"2004","unstructured":"Agha A, Rogers B, Sherlock M, O\u2019Kelly P, Tormey W, Phillips J, Thompson CJ. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89(10):4929\u201336. https:\/\/doi.org\/10.1210\/jc.2004-0511.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1448_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10544-010-9453-y","volume":"12","author":"NJ Kent","year":"2010","unstructured":"Kent NJ, Basabe-Desmonts L, Meade G, MacCraith BD, Corcoran BG, Kenny D, Ricco AJ. Microfluidic device to study arterial shear-mediated platelet-surface interactions in whole blood: reduced sample volumes and well-characterised protein surfaces. Biomed Microdevices. 2010;12(6):987\u20131000. https:\/\/doi.org\/10.1007\/s10544-010-9453-y.","journal-title":"Biomed Microdevices"},{"issue":"1","key":"1448_CR25","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1038\/s41598-017-06959-6","volume":"7","author":"J Cowman","year":"2017","unstructured":"Cowman J, M\u00fcllers S, Dunne E, Ralph A, Ricco AJ, Malone FD, Kenny D. Platelet behaviour on von Willebrand factor changes in pregnancy: consequences of haemodilution and intrinsic changes in platelet function. Sci Rep. 2017;7(1):6354. https:\/\/doi.org\/10.1038\/s41598-017-06959-6.","journal-title":"Sci Rep"},{"key":"1448_CR26","doi-asserted-by":"publisher","first-page":"12235","DOI":"10.1038\/srep12235","volume":"5","author":"J Cowman","year":"2015","unstructured":"Cowman J, Dunne E, Oglesby I, Byrne B, Ralph A, Voisin B, M\u00fcllers S, Ricco AJ, Kenny D. Age-related changes in platelet function are more profound in women than in men. Sci Rep. 2015;5:12235. https:\/\/doi.org\/10.1038\/srep12235.","journal-title":"Sci Rep"},{"issue":"4","key":"1448_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ckj\/sfx148","volume":"11","author":"C Kennedy","year":"2018","unstructured":"Kennedy C, Wong L, Sexton DJ, Cowman J, Oglesby I, Kenny M, Conlon PJ, Kenny D. Successful kidney transplantation normalizes platelet function. Clin Kidney J. 2018;11(4):574\u201380. https:\/\/doi.org\/10.1093\/ckj\/sfx148.","journal-title":"Clin Kidney J"},{"issue":"4","key":"1448_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13239-016-0282-x","volume":"7","author":"A Ralph","year":"2016","unstructured":"Ralph A, Somers M, Cowman J, Voisin B, Hogan E, Dunne H, Dunne E, Byrne B, Kent N, Ricco AJ, Kenny D, Wong S. Computational Tracking of Shear-Mediated platelet interactions with von Willebrand factor. Cardiovasc Eng Technol. 2016;7(4):389\u2013405. https:\/\/doi.org\/10.1007\/s13239-016-0282-x.","journal-title":"Cardiovasc Eng Technol"},{"issue":"4","key":"1448_CR29","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1210\/jcem.84.4.5595","volume":"84","author":"F Borson-Chazot","year":"1999","unstructured":"Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthez\u00e8ne F. Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab. 1999;84(4):1329\u201333. https:\/\/doi.org\/10.1210\/jcem.84.4.5595.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1448_CR30","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bpj.2019.01.040","volume":"116","author":"QM Qi","year":"2019","unstructured":"Qi QM, Dunne E, Oglesby I, Schoen I, Ricco AJ, Kenny D, Shaqfeh ESG. In Vitro Measurement and modeling of platelet adhesion on VWF-Coated Surfaces in Channel Flow. Biophys J. 2019;116(6):1136\u201351. https:\/\/doi.org\/10.1016\/j.bpj.2019.01.040.","journal-title":"Biophys J"},{"issue":"3","key":"1448_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1210\/jcem.87.3.8336","volume":"87","author":"A Colao","year":"2002","unstructured":"Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. J Clin Endocrinol Metab. 2002;87(3):1088\u201393. https:\/\/doi.org\/10.1210\/jcem.87.3.8336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1448_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","volume":"54","author":"A Colao","year":"2001","unstructured":"Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin Endocrinol (Oxf). 2001;54(2):137\u201354. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01218.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1448_CR33","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1210\/jcem.86.5.7464","volume":"86","author":"A Colao","year":"2001","unstructured":"Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab. 2001;86(5):1874\u201381. https:\/\/doi.org\/10.1210\/jcem.86.5.7464.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1448_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11154-020-09560-x","volume":"21","author":"TLC Wolters","year":"2020","unstructured":"Wolters TLC, Netea MG, Riksen NP, Hermus ARMM, Netea-Maier RT. Acromegaly, inflammation and cardiovascular disease: a review. Rev Endocr Metab Disord. 2020;21(4):547\u201368. https:\/\/doi.org\/10.1007\/s11154-020-09560-x.","journal-title":"Rev Endocr Metab Disord"},{"key":"1448_CR35","doi-asserted-by":"publisher","unstructured":"Demirpence M, Yasar HY, Colak A, Akinci B, Yener S, Toprak B, Karademirci I. Mean platelet volume and platelet function analysis in Acromegalic Patients before and after treatment. Acta Endocrinol (Buchar). 2016 Oct-Dec;12(4):401\u20136. https:\/\/doi.org\/10.4183\/aeb.2016.401.","DOI":"10.4183\/aeb.2016.401"},{"issue":"1","key":"1448_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/jc.2004-0477","volume":"90","author":"F Reis","year":"2005","unstructured":"Reis F, Campos MV, Bastos M, Almeida L, Louren\u00e7o M, Ferrer-Antunes CA, Palmeiro A, Santos-Dias JD, Mesquita JF, Carvalheiro M, Teixeira F. Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk. J Clin Endocrinol Metab. 2005;90(1):98\u2013105. https:\/\/doi.org\/10.1210\/jc.2004-0477.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7917","key":"1448_CR37","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/s0140-6736(75)93139-6","volume":"1","author":"GM Besser","year":"1975","unstructured":"Besser GM, Paxton AM, Johnson SA, Moody EJ, Mortimer CH. Impairment of platelet function by growth-hormone release-inhibiting hormone. Lancet. 1975;1(7917):1166\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(75)93139-6.","journal-title":"Lancet"},{"issue":"1","key":"1448_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/ijms24010717","volume":"24","author":"K Karolczak","year":"2023","unstructured":"Karolczak K, Konieczna L, Soltysik B, Kostka T, Witas PJ, Kostanek J, Baczek T, Watala C. Plasma concentration of Cortisol negatively Associates with platelet reactivity in older subjects. Int J Mol Sci. 2023;24(1):717. https:\/\/doi.org\/10.3390\/ijms24010717.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1448_CR39","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1210\/jc.2004-1114","volume":"89","author":"C Giavoli","year":"2004","unstructured":"Giavoli C, Lib\u00e9 R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A, Beck-Peccoz P. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab. 2004;89(11):5397\u2013401. https:\/\/doi.org\/10.1210\/jc.2004-1114.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1448_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/ajcp\/100.2.103","volume":"100","author":"S Mandal","year":"1993","unstructured":"Mandal S, Sarode R, Dash S, Dash RJ. Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitus. Am J Clin Pathol. 1993;100(2):103\u20137. https:\/\/doi.org\/10.1093\/ajcp\/100.2.103.","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"1448_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1055\/s-2007-979115","volume":"29","author":"D Tschoepe","year":"1997","unstructured":"Tschoepe D, Rauch U, Schwippert B. Platelet-leukocyte-cross-talk in diabetes mellitus. Horm Metab Res. 1997;29(12):631\u20135. https:\/\/doi.org\/10.1055\/s-2007-979115.","journal-title":"Horm Metab Res"},{"issue":"8","key":"1448_CR42","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/ndt\/gft103","volume":"28","author":"T Gremmel","year":"2013","unstructured":"Gremmel T, M\u00fcller M, Steiner S, Seidinger D, Koppensteiner R, Kopp CW, Panzer S. Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy. Nephrol Dial Transplant. 2013;28(8):2116\u201322. https:\/\/doi.org\/10.1093\/ndt\/gft103.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1448_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/BF03344122","volume":"29","author":"S Bergamaschi","year":"2006","unstructured":"Bergamaschi S, Giavoli C, Ferrante E, Lania A, Rusconi R, Spada A, Beck-Peccoz P. Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome. J Endocrinol Invest. 2006;29(5):399\u2013404. https:\/\/doi.org\/10.1007\/BF03344122.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1448_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12020-015-0781-9","volume":"53","author":"A Esposito","year":"2016","unstructured":"Esposito A, Capalbo D, De Martino L, Rezzuto M, Di Mase R, Pignata C, Salerno M. Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency. Endocrine. 2016;53(1):192\u20138. https:\/\/doi.org\/10.1007\/s12020-015-0781-9.","journal-title":"Endocrine"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01448-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:44:31Z","timestamp":1700257471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01448-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01448-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study, including methods and experimental protocols was approved by the Beaumont Hospital ethics committee and conducted according to the Helsinki Declaration. All subjects gave written, informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}